Enhancing Laboratory Efficiency and Patient Care: Sysmex XE-2100 Automated Hematology System
The Sysmex XE-2100 Automated Hematology System is engineered to meet the demands of medium to high-volume laboratories, offering an automated solution that exceeds expectations. With the capability to process up to 150 samples per hour, this system significantly enhances workflow efficiency, providing rapid testing without compromising accuracy.
Utilizing the latest advancements in fluorescent flow cytometry and hydrodynamic focusing technologies, the Sysmex XE-2100 delivers exceptional performance in hematological analysis. Its state-of-the-art diode laser bench enables precise measurement and differentiation of cell types in both whole blood and body fluid samples. By harnessing fluorescent technology and hydrodynamic focusing, the XE-2100 reliably distinguishes between normal and abnormal white blood cells (WBCs), red blood cells (RBCs), and platelets (PLTs), minimizing the need for manual interventions.
One of the standout features of the Sysmex XE-2100 is its 6-part differential capability, which includes an Immature Granulocyte Count (IG%). This unique feature provides quantitative results, including metamyelocytes, myelocytes, and promyelocytes, offering valuable insights into the patient's hematological profile.
Another crucial aspect of the XE-2100 is its ability to enumerate Fluorescent Nucleated Red Blood Cells (NRBCs), essential for obtaining accurate WBC and differential counts in pathological samples. The system's fluorescent technology facilitates NRBC measurement in both percentage and absolute count, ensuring improved sensitivity, rapid reporting, and efficient automatic correction of WBC and differential results. Moreover, the advanced separation of NRBCs from WBCs and RBCs contributes to decreased false negative and false positive rates, enhancing diagnostic accuracy.
The NRBC measurement feature is available with every Complete Blood Count (CBC) or as a reflexive testing option, providing clinicians with comprehensive information to aid in patient diagnosis and treatment decisions. Overall, the Sysmex XE-2100 Automated Hematology System represents a cutting-edge solution for laboratories seeking superior performance, efficiency, and accuracy in hematological analysis.
In addition to its exceptional performance in hematological analysis, the Sysmex XE-2100 Automated Hematology System offers improved patient care through its ability to analyze samples with small volumes. Using the capillary mode (pre-dilute analysis mode), the XE-2100 requires only 40μL of whole blood to deliver quality clinical data rapidly and consistently. This feature ensures that even when only limited sample volumes are available, clinicians can obtain accurate and reliable results, enhancing diagnostic efficiency and patient management.
Furthermore, the XE-2100 provides a comprehensive clinical testing menu for both whole blood and body fluids, offering accurate, precise, and sensitive results across a wide range of parameters. With its rapid throughput, the system ensures that physicians receive quality clinically relevant information promptly, aiding in the management and diagnosis of all patients. By delivering timely and accurate results, the XE-2100 facilitates informed decision-making and improves patient outcomes.
One of the key features of the Sysmex XE-2100 is its capability to perform a Fluorescent Reticulocyte Count, known as the "Gold Standard" in reticulocyte testing. This feature is available on the XE-2100, providing on-board retic testing in a dedicated channel and enhancing efficiency in reporting reticulocytes round the clock. Utilizing fluorescent technology, the retic channel offers accurate reticulocyte counting in both percentage and absolute numbers, along with improved immature reticulocyte information (IRF) for early diagnosis and treatment by clinicians. Additionally, it eliminates common interferences from Howell-Jolly bodies, Pappenheimer bodies, and immature reticulocytes, thereby avoiding the need for manual counts and ensuring reliable results.
Moreover, the XE-2100 includes Reticulocyte Hemoglobin Measurement (RET-He), a parameter measured in the reticulocyte channel that assesses the incorporation of iron into erythrocyte hemoglobin. RET-He supports the assessment of anemia and is an established parameter used in KDOQI guidelines for assessing the initial iron status of patients. By providing rapid, direct analysis of an earlier stage of red blood cell (RBC) development, RET-He enables prompt clinical follow-up and supports accurate and sensitive measurement of red cell production. This, in turn, facilitates effective monitoring of costly drug protocols for cell stimulation, ensuring optimal patient care and treatment outcomes.
